PureTech Health
From Wikipedia, the free encyclopedia
PureTech Health is a biotechnology company which develops medicines to combat serious diseases. It is listed on the London Stock Exchange and is a constituent of the FTSE 250 Index.
Quick Facts Company type, Traded as ...
Company type | Public |
---|---|
Industry | Healthcare |
Founded | 2005 |
Headquarters | Boston, United States |
Key people | Christopher Viehbacher (Chairman) Daphne Zohar (CEO) |
Products | Medicines |
Revenue | $15.6 million (2022)[1] |
$(197.8) million (2022)[1] | |
$(37.4) million (2022)[1] | |
Website | puretechhealth |
Close